Financial experts highlight automated investing as a key habit to adopt in 2026 for building a $1 million retirement portfolio. By setting recurring investments into diversified assets, investors can ...
Pfizer shows steady pharmaceutical progress with oncology growth and drug protection strength, shaping healthcare dynamics ...
The U.S. Food and Drug Administration on Friday approved Pfizer and Arvinas' breast cancer drug for patients with an ...
Pfizer (PFE) stock and Arvinas (ARVN) stock are in focus as the FDA approves the companies' breast cancer drug, Veppanu. Read ...
VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...
Pfizer Inc. (NYSE: PFE) is one of the 10 Best Medical Stocks to Buy Under $30. On April 20, Pfizer Inc. (NYSE:PFE) announced, ...
The pharmaceutical giant just extended the lifespan of one of its top drugs.
Pfizer said on Wednesday its drug Elrexfio met the main goal in a late-stage trial that tested the blood cancer treatment ...
Pfizer Inc. (NYSE:PFE) is one of the most active US stocks to buy right now. On April 28, Pfizer entered into settlement ...
Pfizer (PFE) stock is in focus as a trial for the company's Elrexfio multiple myeloma drug hit the main goal with patients on ...
(NYSE: PFE) today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO ® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM ...
The pharmaceutical company has been investing in its future growth, but whether its efforts will pay off is a big question ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results